These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19140206)

  • 1. Prognostic value of combination of heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values.
    Liyan C; Jie Z; Xiaozhou H
    J Clin Lab Anal; 2009; 23(1):14-8. PubMed ID: 19140206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care.
    Willemsen RT; van Severen E; Vandervoort PM; Grieten L; Buntinx F; Glatz JF; Dinant GJ
    Eur J Gen Pract; 2015; 21(3):156-63. PubMed ID: 25751665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
    Figiel Ł; Wraga M; Bednarkiewicz Z; Lipiec P; Smigielski J; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2011; 69(1):1-6. PubMed ID: 21267954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome.
    Hjortshøj S; Kristensen SR; Ravkilde J
    Am J Emerg Med; 2010 Feb; 28(2):170-6. PubMed ID: 20159386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
    Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
    Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain.
    Inoue K; Suwa S; Ohta H; Itoh S; Maruyama S; Masuda N; Sugita M; Daida H
    Circ J; 2011; 75(12):2813-20. PubMed ID: 21937835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Manchester Acute Coronary Syndromes (MACS) decision rule: validation with a new automated assay for heart-type fatty acid binding protein.
    Body R; Burrows G; Carley S; Lewis PS
    Emerg Med J; 2015 Oct; 32(10):769-74. PubMed ID: 25539884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome.
    Ishii J; Ozaki Y; Lu J; Kitagawa F; Kuno T; Nakano T; Nakamura Y; Naruse H; Mori Y; Matsui S; Oshima H; Nomura M; Ezaki K; Hishida H
    Clin Chem; 2005 Aug; 51(8):1397-404. PubMed ID: 15951316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.
    Goel H; Melot J; Krinock MD; Kumar A; Nadar SK; Lip GYH
    Ann Med; 2020 Dec; 52(8):444-461. PubMed ID: 32697102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department.
    Charpentier S; Ducassé JL; Cournot M; Maupas-Schwalm F; Elbaz M; Baixas C; Juchet H; Lang T; Lauque D
    Acad Emerg Med; 2010 Jan; 17(1):27-35. PubMed ID: 20078436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome.
    Goodacre S; Thokala P; Carroll C; Stevens JW; Leaviss J; Al Khalaf M; Collinson P; Morris F; Evans P; Wang J
    Health Technol Assess; 2013; 17(1):v-vi, 1-188. PubMed ID: 23331845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.
    Bank IE; Dekker MS; Hoes AW; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; Timmers L; de Kleijn DP; Glatz JF; Mosterd A
    Eur Heart J Acute Cardiovasc Care; 2016 Aug; 5(4):364-74. PubMed ID: 25906779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the (Troponin-only) Manchester ACS decision aid with a contemporary cardiac troponin I assay.
    Va Den Berg P; Burrows G; Lewis P; Carley S; Body R
    Am J Emerg Med; 2018 Apr; 36(4):602-607. PubMed ID: 29079376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform.
    Orak M; Ustündağ M; Güloğlu C; Ozhasenekler A; Alyan O; Kale E
    Am J Emerg Med; 2010 Oct; 28(8):891-6. PubMed ID: 20825920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia modified albumin, a marker of acute ischemic events: a pilot study.
    Talwalkar SS; Bon Homme M; Miller JJ; Elin RJ
    Ann Clin Lab Sci; 2008; 38(2):132-7. PubMed ID: 18469358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of heart-type fatty acid binding protein determined by the rapid qualitative chromatographic immunoassay method for the detection of minor myocardial damage in patients presenting with non-ST elevation acute coronary syndrome.
    Çavuşoğlu Y; Gök B; Demirüstü C; Birdane A; Görenek B; Ata N
    Anadolu Kardiyol Derg; 2012 Nov; 12(7):584-90. PubMed ID: 22804980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome.
    Nakata T; Hashimoto A; Hase M; Tsuchihashi K; Shimamoto K
    Cardiology; 2003; 99(2):96-104. PubMed ID: 12711885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of a 4,183 Da peptide of dermcidin protein in the early diagnosis and differential diagnosis of acute coronary syndrome].
    Kai F; Lifeng L; Haijing S; Xianhua L; Hu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Dec; 27(12):970-4. PubMed ID: 27318339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
    Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
    Heart Vessels; 2016 Jun; 31(6):907-17. PubMed ID: 26081026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.